TABLE 3.
The vaccine type, the dose that triggered the HZ reactivation, and the duration from the vaccination to skin reaction
| No. of cases for analysis | No. of articles cited for analysis and the first author of the article not cited for analysis (out of 20 articles in Table 1) | |||||||
|---|---|---|---|---|---|---|---|---|
| Vaccine type | 399 | BNT162b2(Pfizer) | 351 | 20 | None | |||
| mRNA‐1273 (Moderna) | 28 | |||||||
| AZD1222 (AstraZeneca) | 14 | |||||||
| mRNA COVID vaccine (not specified) | 1 | |||||||
| inactivated SARS‐CoV‐2 vaccine | 5 | |||||||
| The dose reactivating HV | 399 | First dose | 77 | 20 | None | |||
| Second dose | 32 | |||||||
| Unknown (or needed only one shot) | 290 | |||||||
| Duration (days) | 59 | Minimum | 1 | 16 | Barda | Furer | McMahon | Català |
| Maximum | 24 | |||||||
| Mean | 6.75 | |||||||